June 4, 2020 / 4:31 PM / a month ago

BRIEF-Algernon Receives U.S. FDA Clearance For Multinational Phase 2B/3 Human Study To Evaluate Ifenprodil As A Potential Therapeutic For Covid-19

June 4 (Reuters) - Algernon Pharmaceuticals Inc:

* ALGERNON RECEIVES U.S. FDA CLEARANCE FOR MULTINATIONAL PHASE 2B/3 HUMAN STUDY TO EVALUATE IFENPRODIL AS A POTENTIAL THERAPEUTIC FOR COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below